Drug companies including Sanofi S.A. and Pfizer Inc. have brought in some of the nation’s top defense attorneys in more than two dozen lawsuits brought over last month’s recall of over-the-counter heartburn medication Zantac.

Anand Agneshwar, co-chairman of Arnold & Porter Kaye Scholer’s products liability litigation practice, made an appearance Wednesday before the U.S. Judicial Panel on Multidistrict Litigation on behalf of Sanofi, which voluntarily recalled Zantac on Oct. 18 after the U.S. Food and Drug Administration discovered it contained an ingredient linked to cancer. Mark Cheffo, co-chairman of the products liability and mass torts practice at Dechert, appeared for GlaxoSmithKline, which first received FDA approval to sell Zantac in 1983. GlaxoSmithKline has a U.S. unit based in Philadelphia.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]